NCT07112209 2025-08-08
Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer
Zhujiang Hospital
Phase NA Enrolling by invitation
Clinical Trials
1 trialsPathological and Imaging Examinations Confirmed Metastatic Prostate Cancer × Docetaxel × Genitourinary × Clear all